Chronic Idiopathic Constipation (CIC) Drugs Market Report

Global and Region Chronic Idiopathic Constipation (CIC) Drugs Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：186
  • REPORT CODE：GMM900167
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Chronic Idiopathic Constipation (CIC) Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Chronic Idiopathic Constipation (CIC) Drugsmarket, defines the market attractiveness level of Chronic Idiopathic Constipation (CIC) Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Chronic Idiopathic Constipation (CIC) Drugs industry, describes the types of Chronic Idiopathic Constipation (CIC) Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Chronic Idiopathic Constipation (CIC) Drugs market and the development prospects and opportunities of Chronic Idiopathic Constipation (CIC) Drugs industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Chronic Idiopathic Constipation (CIC) Drugs market in Chapter 13.

    By Player:

    • Salix Pharmaceuticals

    • Sucampo Pharmaceuticals

    • Progenics Pharmaceuticals

    • Chugai Pharmaceutical

    • GlaxoSmithKline

    • Roche Holding

    • Ironwood Pharmaceuticals

    • Actavis

    • Sanofi

    • Ferring International Center

    • Synergy Pharmaceuticals

    • Bayer

    • Pfizer

    By Type:

    • Lubiprostone

    • Linaclotide

    • Others

    By End-User:

    • Hospitals & Clinics

    • Ambulatory Surgical Centres

    • Long Term Care Centres

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Chronic Idiopathic Constipation (CIC) Drugs Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Chronic Idiopathic Constipation (CIC) Drugs Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Chronic Idiopathic Constipation (CIC) Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Chronic Idiopathic Constipation (CIC) Drugs Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Chronic Idiopathic Constipation (CIC) Drugs Market Analysis and Outlook to 2022

    • 7.1 Global Chronic Idiopathic Constipation (CIC) Drugs Consumption (2017-2022)

    • 7.2 United States Chronic Idiopathic Constipation (CIC) Drugs Consumption (2017-2022)

    • 7.3 Europe Chronic Idiopathic Constipation (CIC) Drugs Consumption (2017-2022)

    • 7.4 China Chronic Idiopathic Constipation (CIC) Drugs Consumption (2017-2022)

    • 7.5 Japan Chronic Idiopathic Constipation (CIC) Drugs Consumption (2017-2022)

    • 7.6 India Chronic Idiopathic Constipation (CIC) Drugs Consumption (2017-2022)

    • 7.7 South Korea Chronic Idiopathic Constipation (CIC) Drugs Consumption (2017-2022)

    8 Region and Country-wise Chronic Idiopathic Constipation (CIC) Drugs Market Analysis and Outlook to 2028

    • 8.1 Global Chronic Idiopathic Constipation (CIC) Drugs Consumption Forecast (2022-2028)

    • 8.2 United States Chronic Idiopathic Constipation (CIC) Drugs Consumption Forecast (2022-2028)

    • 8.3 Europe Chronic Idiopathic Constipation (CIC) Drugs Consumption Forecast (2022-2028)

    • 8.4 China Chronic Idiopathic Constipation (CIC) Drugs Consumption Forecast (2022-2028)

    • 8.5 Japan Chronic Idiopathic Constipation (CIC) Drugs Consumption Forecast (2022-2028)

    • 8.6 India Chronic Idiopathic Constipation (CIC) Drugs Consumption Forecast (2022-2028)

    • 8.7 South Korea Chronic Idiopathic Constipation (CIC) Drugs Consumption Forecast (2022-2028)

    9 Global Chronic Idiopathic Constipation (CIC) Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Chronic Idiopathic Constipation (CIC) Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Lubiprostone Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Linaclotide Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Chronic Idiopathic Constipation (CIC) Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals & Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Ambulatory Surgical Centres Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Long Term Care Centres Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Chronic Idiopathic Constipation (CIC) Drugs Market Outlook by Types and Applications to 2028

    • 10.1 Global Chronic Idiopathic Constipation (CIC) Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Lubiprostone Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Linaclotide Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Chronic Idiopathic Constipation (CIC) Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals & Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Ambulatory Surgical Centres Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Long Term Care Centres Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Chronic Idiopathic Constipation (CIC) Drugs Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Chronic Idiopathic Constipation (CIC) Drugs Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Chronic Idiopathic Constipation (CIC) Drugs Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Chronic Idiopathic Constipation (CIC) Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Chronic Idiopathic Constipation (CIC) Drugs Market Competitive Analysis

    • 14.1 Salix Pharmaceuticals

      • 14.1.1 Salix Pharmaceuticals Company Details

      • 14.1.2 Salix Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Salix Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product and Service

    • 14.2 Sucampo Pharmaceuticals

      • 14.2.1 Sucampo Pharmaceuticals Company Details

      • 14.2.2 Sucampo Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Sucampo Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product and Service

    • 14.3 Progenics Pharmaceuticals

      • 14.3.1 Progenics Pharmaceuticals Company Details

      • 14.3.2 Progenics Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Progenics Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product and Service

    • 14.4 Chugai Pharmaceutical

      • 14.4.1 Chugai Pharmaceutical Company Details

      • 14.4.2 Chugai Pharmaceutical Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Chugai Pharmaceutical Chronic Idiopathic Constipation (CIC) Drugs Product and Service

    • 14.5 GlaxoSmithKline

      • 14.5.1 GlaxoSmithKline Company Details

      • 14.5.2 GlaxoSmithKline Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 GlaxoSmithKline Chronic Idiopathic Constipation (CIC) Drugs Product and Service

    • 14.6 Roche Holding

      • 14.6.1 Roche Holding Company Details

      • 14.6.2 Roche Holding Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Roche Holding Chronic Idiopathic Constipation (CIC) Drugs Product and Service

    • 14.7 Ironwood Pharmaceuticals

      • 14.7.1 Ironwood Pharmaceuticals Company Details

      • 14.7.2 Ironwood Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Ironwood Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product and Service

    • 14.8 Actavis

      • 14.8.1 Actavis Company Details

      • 14.8.2 Actavis Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Actavis Chronic Idiopathic Constipation (CIC) Drugs Product and Service

    • 14.9 Sanofi

      • 14.9.1 Sanofi Company Details

      • 14.9.2 Sanofi Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Sanofi Chronic Idiopathic Constipation (CIC) Drugs Product and Service

    • 14.10 Ferring International Center

      • 14.10.1 Ferring International Center Company Details

      • 14.10.2 Ferring International Center Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Ferring International Center Chronic Idiopathic Constipation (CIC) Drugs Product and Service

    • 14.11 Synergy Pharmaceuticals

      • 14.11.1 Synergy Pharmaceuticals Company Details

      • 14.11.2 Synergy Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Synergy Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product and Service

    • 14.12 Bayer

      • 14.12.1 Bayer Company Details

      • 14.12.2 Bayer Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Bayer Chronic Idiopathic Constipation (CIC) Drugs Product and Service

    • 14.13 Pfizer

      • 14.13.1 Pfizer Company Details

      • 14.13.2 Pfizer Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Pfizer Chronic Idiopathic Constipation (CIC) Drugs Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Chronic Idiopathic Constipation (CIC) Drugs

    • Figure Chronic Idiopathic Constipation (CIC) Drugs Picture

    • Table Global Chronic Idiopathic Constipation (CIC) Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Chronic Idiopathic Constipation (CIC) Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Chronic Idiopathic Constipation (CIC) Drugs Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Chronic Idiopathic Constipation (CIC) Drugs Consumption by Country (2017-2022)

    • Figure United States Chronic Idiopathic Constipation (CIC) Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Chronic Idiopathic Constipation (CIC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure China Chronic Idiopathic Constipation (CIC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Chronic Idiopathic Constipation (CIC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Chronic Idiopathic Constipation (CIC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Chronic Idiopathic Constipation (CIC) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Chronic Idiopathic Constipation (CIC) Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Chronic Idiopathic Constipation (CIC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Chronic Idiopathic Constipation (CIC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Chronic Idiopathic Constipation (CIC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Chronic Idiopathic Constipation (CIC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Chronic Idiopathic Constipation (CIC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Chronic Idiopathic Constipation (CIC) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lubiprostone Consumption and Growth Rate (2017-2022)

    • Figure Global Linaclotide Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals & Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Ambulatory Surgical Centres Consumption and Growth Rate (2017-2022)

    • Figure Global Long Term Care Centres Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Lubiprostone Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Linaclotide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals & Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ambulatory Surgical Centres Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Long Term Care Centres Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Chronic Idiopathic Constipation (CIC) Drugs Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Chronic Idiopathic Constipation (CIC) Drugs Export by Region (Top 5 Countries) (2017-2028)

    • Table Salix Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Salix Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Salix Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product and Service

    • Table Sucampo Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Sucampo Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sucampo Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product and Service

    • Table Progenics Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Progenics Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Progenics Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product and Service

    • Table Chugai Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Chugai Pharmaceutical Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Chugai Pharmaceutical Chronic Idiopathic Constipation (CIC) Drugs Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Chronic Idiopathic Constipation (CIC) Drugs Product and Service

    • Table Roche Holding (Foundation Year, Company Profile and etc.)

    • Table Roche Holding Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Holding Chronic Idiopathic Constipation (CIC) Drugs Product and Service

    • Table Ironwood Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Ironwood Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ironwood Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product and Service

    • Table Actavis (Foundation Year, Company Profile and etc.)

    • Table Actavis Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Actavis Chronic Idiopathic Constipation (CIC) Drugs Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Chronic Idiopathic Constipation (CIC) Drugs Product and Service

    • Table Ferring International Center (Foundation Year, Company Profile and etc.)

    • Table Ferring International Center Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ferring International Center Chronic Idiopathic Constipation (CIC) Drugs Product and Service

    • Table Synergy Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Synergy Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Synergy Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Product and Service

    • Table Bayer (Foundation Year, Company Profile and etc.)

    • Table Bayer Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Chronic Idiopathic Constipation (CIC) Drugs Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Chronic Idiopathic Constipation (CIC) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Chronic Idiopathic Constipation (CIC) Drugs Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US